Cite

HARVARD Citation

    Gong, T. et al. (2021). A nanodrug incorporating siRNA PD-L1 and Birinapant for enhancing tumor immunotherapy. Biomaterials science. pp. 8007-8018. [Online]. 
  
Back to record